Replication-competent gamma-retrovirus Mo-MuLV expressing green fluorescent protein as efficient tool for screening of inhibitors of retroviruses that use heparan sulfate as primary cell receptor-Reference-Cited by-同舟云学术

Replication-competent gamma-retrovirus Mo-MuLV expressing green fluorescent protein as efficient tool for screening of inhibitors of retroviruses that use heparan sulfate as primary cell receptor

Published:2012-05 Issue:3 Volume:46 Page:457-466
ISSN:0026-8933
Container-title:Molecular Biology
language:en
Short-container-title:Mol Biol

Author:

Stepanov O. A.,Prokof’eva M. M.,Stocking K.,Varlamov V. P.,Levov A. N.,Vikhoreva G. A.,Spirin P. V.,Mikhailov S. N.,Prassolov V. S.

Publisher

Pleiades Publishing Ltd

Subject

Structural Biology,Biophysics

Link

http://link.springer.com/content/pdf/10.1134/S0026893312030119.pdf

Reference34 articles.

1. Stocking C., Kozak C.A. 2008. Murine endogenous retroviruses. Cell Mol. Life Sci. 65, 3383–3398.

2. Jern P., Coffin J.M. 2008. Effects of retroviruses on host genome function. Annu. Rev. Genet. 42, 709–732.

3. De Clercq E. 2009. Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV. Int. J. Antimicrob Agents. 33, 307–320.

4. Cladera J., Martin I., O’shea P. 2001. The fusion domain of HIV gp41 interacts specifically with heparan sulfate on the T-lymphocyte cell surface. EMBO J. 20, 19–26.

5. Prokofjeva M.M., Spirin P.V., Yanvarev D.V., Ivanov A.V., Novikov M.S., Stepanov O.A., Gottikh M.B., Kochetkov S.N., Fehse B., Stocking C., Prassolov V.S. 2011. Screening of potential HIV-1 inhibitors/replication blockers using secure lentiviral in vitro system. Acta Naturae. 3(4), 55–65.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative study of HIV-1 inhibition efficiency by carrageenans from red seaweeds family gigartinaceae, Tichocarpaceae and Phyllophoraceae;Heliyon;2024-07

2. Nucleoside Analog 2′,3′-Isopropylidene-5-Iodouridine as Novel Efficient Inhibitor of HIV-1;Pharmaceutics;2023-09-27

3. Anti-COVID-19 Credentials of Chitosan Composites and Derivatives: Future Scope?;Antibiotics;2023-03-28

4. Chitosan and its derivatives as polymeric anti-viral therapeutics and potential anti-SARS-CoV-2 nanomedicine;Carbohydrate Polymers;2022-08

5. Antiviral Potency of Chitosan, Its Derivatives, and Nanocomposites;Chitosan-Based Nanocomposite Materials;2022